Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 1.00 |
| ▸ | SLC1A2 | P43004 | 7/20 | 0.74 |
| ▸ | SLC1A3 | P43003 | 6/20 | 0.74 |
| ▸ | SLC1A1 | P43005 | 7/20 | 0.62 |
| ▸ | GRIK1 | P39086 | 9/20 | 0.52 |
| ▸ | GRIK2 | Q13002 | 6/20 | 0.52 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.50 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.48 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.48 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.48 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.48 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Leucine SCHEMBL8568063 | 1.00 | SLC7A5 (1.00) | SLC7A5SLC1A2SLC1A3SLC1A1GRIK1 | |
| D-Leucine SCHEMBL9449950 | 1.00 | SLC7A5 (1.00) | SLC7A5SLC1A2SLC1A3SLC1A1GRIK1 | |
| Leucine SCHEMBL20362356 | 1.00 | — | — | |
| Leucine SCHEMBL3888 | 1.00 | — | — | |
| D-Leucine SCHEMBL42012 | 1.00 | — | — | |
| Leucine SCHEMBL25241602 | 1.00 | SLC7A5 (1.00) | SLC7A5SLC1A2SLC1A3SLC1A1GRIK1 | |
| Leucine SCHEMBL8568060 | 1.00 | SLC7A5 (1.00) | SLC7A5SLC1A2SLC1A3SLC1A1GRIK1 | |
| Leucine SCHEMBL331557 | 1.00 | SLC7A5 (1.00) | SLC7A5SLC1A2SLC1A3SLC1A1GRIK1 | |
| Leucine SCHEMBL2478164 | 1.00 | SLC7A5 (1.00) | SLC7A5SLC1A2SLC1A3SLC1A1GRIK1 | |
| D-Leucine SCHEMBL9100148 | 1.00 | SLC7A5 (1.00) | SLC7A5SLC1A2SLC1A3SLC1A1GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10471034-B2 | Amino acid compositions and methods for the treatment of liver diseases | AXCELLA HEALTH INC. (US) | 2019-11-12 | — | — | US | claimed |
| CN-109402074-A | Monooxygenase mutant and its application | 凯莱英医药集团（天津）股份有限公司 | 2019-03-01 | — | — | CN | claimed |
| CN-105510254-B | A kind of method for controlling the leucine for using extraction method to produce to manufacture Amino Acid Compound Injection crystal for raw material | 宜昌三峡制药有限公司 | 2017-12-15 | — | — | CN | claimed |
| CN-101781325-A | Gallium salicylaldehyde amino acid Schiff base quaternary coordination compound, preparation method and application thereof | UNIV BEIJING NORMAL | 2010-07-21 | — | — | CN | claimed |
| US-7585333-B2 | Fluorescent whitening agent, for whitening synthetic or natural organic materials, especially paper and for the fluorescent whitening and improvement of sun protection factors of textile materials | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2009-09-08 | — | — | US | claimed |
| US-20080307585-A1 | Fluorescent whitening agent, for whitening synthetic or natural organic materials, especially paper and for the fluorescent whitening and improvement of sun protection factors of textile materials | CIBA SPECIALTY CHEMICALS CORP. | 2008-12-18 | — | — | US | claimed |
| CN-1325063-C | L-amino acid water-soluble pearl powder and its preparing method | SONG TINGSHENG (CN) | 2007-07-11 | — | — | CN | claimed |
| CN-1709282-A | L-amino acid water-soluble pearl powder and its preparing method | SONG TINGSHENG (CN) | 2005-12-21 | — | — | CN | claimed |
| US-20050203221-A1 | Whitening pigments | CIBA SPECIALTY CHEMICALS CORP. | 2005-09-15 | — | — | US | claimed |
| CN-1353699-A | Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents | REDDY RESEARCH FOUNDATION (IN) | 2002-06-12 | — | — | CN | claimed |
| US-12582623-B2 | Composition comprising EPA, MA and leucine for improving muscle function | N.V. NUTRICIA (NL) | 2026-03-24 | — | — | US | disclosed |
| EP-3487916-B1 | FUNCTIONALIZED PARTICULATE BICARBONATE AS BLOWING AGENT, FOAMABLE POLYMER COMPOSITION CONTAINING IT, AND ITS USE IN MANUFACTURING A THERMOPLASTIC FOAMED POLYMER | SOLVAY (BE) | 2025-09-03 | — | — | EP | disclosed |
| US-20250241330-A1 | PROCESS FOR TREATING PROTEIN-CONTAINING COMPOSITIONS | NESTLE SA (CH) | 2025-07-31 | — | — | US | disclosed |
| EP-4574161-A1 | PROTEIN SUBSTITUTION COMPOSITION | RenaCare NEPHROMED GmbH (DE) | 2025-06-25 | — | — | EP | disclosed |
| CN-119654071-A | Bacterial compositions and methods for promoting plant growth | 塔斯马尼亚大学 | 2025-03-18 | — | — | CN | disclosed |
| CN-1179097-A | Carrier particles for dry powder inhalers | CO ORDINATED DRUG DEV (GB) | 1998-04-15 | — | — | CN | disclosed |
| EP-0504168-A4 | SYNTHETIC CALCITONIN PEPTIDES | — | 1993-09-22 | — | — | EP | disclosed |
| EP-0504168-A1 | SYNTHETIC CALCITONIN PEPTIDES | VICAL, INC. (US) | 1992-09-23 | — | — | EP | disclosed |
| WO-1991007978-A1 | SYNTHETIC CALCITONIN PEPTIDES | VICAL, INC. (US) | 1991-06-13 | — | — | WO | disclosed |
| US-4871716-A | CROSSLINKED PROTEIN OR POLYPEPTIDE | UNIVERSITY OF FLORIDA (US) | 1989-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12582623-B2 | Composition comprising EPA, MA and leucine for improving muscle function | ELOVL1, ELOVL3, ELOVL5 | SLC7A5 1386/4885SLC1A2 2605/4885SLC1A3 2008/4885 |
| US-20050203221-A1 | Whitening pigments | YTHDC1, TRPC1, AOC1 | SLC7A5 894/4885SLC1A2 3382/4885SLC1A3 3010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.